دورية أكاديمية
1st Line Pembrolizumab in Treatment of Stage IV NSCLC Patients – A Pattern of Failure Analysis with Associated Survival Outcomes
العنوان: | 1st Line Pembrolizumab in Treatment of Stage IV NSCLC Patients – A Pattern of Failure Analysis with Associated Survival Outcomes |
---|---|
المؤلفون: | All, S., Rashdan, S., Gerber, D.E., Hughes, R., Lohrey, J., Dowell, J., Westover, K.D., Vo, D.T., Iyengar, P. |
المصدر: | In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e360-e360 |
قاعدة البيانات: | ScienceDirect |
تدمد: | 03603016 |
---|---|
DOI: | 10.1016/j.ijrobp.2022.07.1477 |